Expression of Herpes Virus Entry Mediator (HVEM) in the Cornea and Trigeminal Ganglia of Normal and HSV-1 Infected Mice

REFERENCES

• Easty DL, Carter C, Funk A. Systemic immunity in herpetic keratitis. Br J Ophtalmol. 1981;65:82–88.
   PubMed Web of Science ®Google Scholar
• Liesegang TJ. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minnesota, 1950 through 1982. Arch Ophtalmol. 1989;107:1160–1165.
   PubMed Web of Science ®Google Scholar
• Whitley RJ. Herpes simplex viruses. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 4th ed. Philadelphia: Lippincott-Raven; 2001:2461–2509.
   Google Scholar
• Kaye S, Choudhari A. Herpes simplex keratitis. Prog Retin Eye Res. 2006;25:355–380.
   PubMed Web of Science ®Google Scholar
• Mott KR, Bresee CJ, Allen SJ, BenMohamed L, Wechsler SL, Ghiasi H. Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice. J Virol. 2009;83:2246–2254.
   PubMed Web of Science ®Google Scholar
• Toma HS, Murina AT, Areaux RG Jr, Neumann DM, Bhattacharjee PS, Foster TP, Kaufman HE, Hill JM. Ocular HSV-1 latency, reactivation, and recurrent disease. Semin Ophthalmol. 2008;23:249–273.
   PubMedGoogle Scholar
• Valyi-Nagy T, Shukla D, Engelhard HH, Kavouras J, Scanlan P. Latency strategies of alphaherpesviruses: Herpes simplex virus and varicella-zoster virus latency in neurons. In: Minarovits J, Gonczol E, Valyi-Nagy T, eds. Chapter 1. Latency Strategies of Herpesviruses. New York: Springer; 2007:1–36.
   Google Scholar
• Doymaz, MZ, Rouse, BT. Immunopathology of herpes simplex virus infections. In: Rouse BT, ed. Herpes Simplex Virus. Pathogenesis, Immunobiology, and Control. Berlin: Springer; 1992:121–136.
   Google Scholar
• Spear PG. Entry of alphaherpesviruses into cells. Sem Virol. 1993;4:167–180.
   Web of Science ®Google Scholar
• Spear PG, Eisenberg RJ, Cohen GH. Three classes of cell surface receptors for entry. Virology. 2000;275:1–8.
   PubMed Web of Science ®Google Scholar
• Shukla D, Spear PG. Herpesviruses and heparan sulfate: An intimate relationship in aid of viral entry. J Clin Invest. 2001;108:503–510.
   PubMed Web of Science ®Google Scholar
• Taylor JM, Lin E, Susmarski N, Yoon M, Ware AF, Pfeffer K, Miyoshi J, Takai Y, Spear PG. Alternative entry receptors for herpes simplex virus and their roles in disease. Cell Host Microbe. 2007;2:19–28.
   PubMed Web of Science ®Google Scholar
• Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH., Eisenberg RJ, Rosenberg RD, Spear PG. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell. 1999;99:13–22.
   PubMed Web of Science ®Google Scholar
• Eberle F, Dubreuil P, Mattei MG, Devilard E, Lopez M. The human PRR2 gene, related to the human poliovirus receptor gene (PVR), is the true homolog of the murine MPH gene. Gene. 1995;159:267–272.
   PubMed Web of Science ®Google Scholar
• Lopez M, Eberle F, Mattei MG, Gabert J, Birg F, Bardin F, Maroc C, Dubreuil P. Complementary DNA characterization and chromosomal localization of a human gene related to the poliovirus receptor-encoding gene. Gene. 1995;155:261–265.
   PubMed Web of Science ®Google Scholar
• Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG. Entry of alphaherpesviruses mediated poliovirus receptor-related protein 1 and poliovirus receptor. Science. 1998;280:1618–1620.
   PubMed Web of Science ®Google Scholar
• Warner MS, Geraghty RJ, Martinez WM, Montgomery RI, Whitbeck JC, Xu R, Eisenberg RJ, Cohen GH, Spear PG. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology. 1998;246:179–189.
   PubMed Web of Science ®Google Scholar
• Valyi-Nagy T, Sheth V, Clement C, Tiwari V, Scanlan P, Kavouras JH, Leach L, Guzman-Hartman G, Dermody TS, Shukla D. Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye. Curr Eye Res. 2004;29:303–309.
   PubMed Web of Science ®Google Scholar
• Shukla D, Scanlan PM, Tiwari V, Sheth V, Clement C, Guzman-Hartman G, Dermody TS, Valyi-Nagy T. Expression of nectin-1 in normal and herpes simplex virus type 1-infected murine brain. Appl Immunhistochem Mol Morphol. 2006;14:341–347.
   PubMedGoogle Scholar
• Guzman G, Oh SD, Shukla D, Engelhard HH, Valyi-Nagy T. Expression of entry receptor nectin-1 of Herpes simplex virus 1 and/or Herpes simplex virus 2 in normal and neoplastic human nervous system tissues. Acta Virol. 2006;50:59–66.
   PubMed Web of Science ®Google Scholar
• Richart SM, Simpson SA, Krummenacher C, Whitbeck JC, Pizer LI, Cohen GH, Eisenberg RJ, Wilcox CL. Entry of herpes simplex virus type 1 into primary sensory neurons in vitro is mediated by nectin-1/HveC. J Virol. 2003;77:3307–3311.
   PubMed Web of Science ®Google Scholar
• Simpson SA, Manchak MD, Hager EJ, Krummenacher C, Whitbeck JC, Levin MJ, Freed CR, Wilcox CL, Cohen GH, Eisenberg RJ, Pizer LI. Nectin-1/HveC mediates herpes simplex virus type 1 entry into primary human sensory neurons and fibroblasts. J Neurovirol. 2005;11:208–218.
   PubMed Web of Science ®Google Scholar
• Tiwari V, Clement C, Xu D, Valyi-Nagy T, Yue BY, Liu J, Shukla D. A role for 3-O sulfated heparan sulfate as the receptor for herpes simplex virus type-1 entry into primary human corneal fibroblasts. J Virol. 2006;80: 8970–8980.
   PubMed Web of Science ®Google Scholar
• Tiwari V, Shukla SY, Yue BY, Shukla D. Herpes simplex virus type 2 entry into cultured human corneal fibroblasts is mediated by herpesvirus entry mediator. J Gen Virol. 2007;88:2106–2110.
   PubMed Web of Science ®Google Scholar
• Tiwari V, Clement C, Scanlan PM, Kowlessur D, Yue BY, Shukla D. A role for herpesvirus entry mediator for herpes simplex virus 1 entry into primary human trabecular meshwork cells. J Virol. 2005;79:13173–13179.
   PubMed Web of Science ®Google Scholar
• Akhtar J, Tiwari V, Oh M, Kovacs M, Jani A, Kovacs SK, Valyi-Nagy T, Shukla D. HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium. Invest Ophthal Vis Sci. 2008;49:4026–4035.
   PubMed Web of Science ®Google Scholar
• Montgomery RI, Warner MS, Lum BJ, Spear PG. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell. 1996;87:427–436.
   PubMed Web of Science ®Google Scholar
• Murphy KM, Nelson CA, Sedy JR. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol. 2006;6:671–681.
   PubMed Web of Science ®Google Scholar
• Wang Y, Subudhi SK, Anders RA, Lo J, Sun Y, Blink S, Wang Y, Wang J, Liu X, Mink K, Degrandi D, Pfeffer K, Fu YX. The role of herpesvirus entry mediator as a negative regulator of T-cell mediated responses. J Clin Invest. 2005;115:711–717.
   PubMed Web of Science ®Google Scholar
• Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol. 2005;23:23–68.
   PubMed Web of Science ®Google Scholar
• Gray PV, Aggarwal BB, Benton CV, Bringmann TS, Henzel WJ, Jarrett JA, Leung DW, Moffat B, Ng P, Svedersky LP, et al. Cloning and expression of cDNA for human lymphotoxin, a lymphokin with tumor necrosis activity. Nature. 1984;312:721–724.
   PubMed Web of Science ®Google Scholar
• Rooney IA, Butrivich KD, Glass AA, Borboroglu S, Benedict CA, Whitbeck JC, Cohen GH, Eisenberg RJ, Ware CF. The lymphotoxin-β receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J Biol Chem. 2000;275:14307–14315.
   PubMed Web of Science ®Google Scholar
• Loetscher H, Gentz R, Zulauf M, Lustig A, Tabuchi H, Schlager E-J, Brockhurst M, Gallati H, Manneberg M, Lesslauer W. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. J Biol Chem. 1991;266:18324–18329.
   PubMed Web of Science ®Google Scholar
• Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D, Tsien RY, Lenardo MJ. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science. 2000;288:2354–2357.
   PubMed Web of Science ®Google Scholar
• Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell. 1994;76:959–962.
   PubMed Web of Science ®Google Scholar
• Kwon BS, Tan KB, Ni J, Oh KO, Lee ZH, Kim KK, Kim YJ, Wang S, Gentz R, Yu GL, Harrop J, Lyn SD, Silverman C, Porter TG. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem. 1997;272:14272–14276.
   PubMed Web of Science ®Google Scholar
• Hung SL, Cheng YY, Wang YH, Chang KW, Chen YT. Expression and roles of herpesvirus entry mediators A and C in cells of oral origin. Oral Microbiol Immunol. 2002;17:215–223.
   PubMedGoogle Scholar
• Valyi-Nagy T, Gesser RM, Raengsakulrach B, Deshmane SL, Randazzo BP, Dillner AJ, Fraser NW. A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement. Virology. 1994;199:484–490.
   PubMed Web of Science ®Google Scholar
• Milatovic D, Zhang Y, Olson SJ, Montine KS, Roberts LJ, Morrow JD, Dermody TS, Montine TJ, Valyi-Nagy T. Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4 neuroprostanes. J Neurovirol. 2002;8:297–307.
   Web of Science ®Google Scholar
• Valyi-Nagy T, Olson SJ, Valyi-Nagy K, Montine TJ, Dermody TS. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology. 2000;278:309–321.
   PubMed Web of Science ®Google Scholar
• Carr HS, Halford WP, Veress LA, Noisakran S, Perng GC, Wechsler SL. The persistent elevated cytokine mRNA levels in trigeminal of mice latently infected with HSV-1 are not due to the presence of latency associated transcript (LAT) RNAs. Virus Res. 1998;54:1–8.
   PubMed Web of Science ®Google Scholar
• Liu T, Tang Q, Hendricks RL. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol. 1996;70:264–271.
   PubMed Web of Science ®Google Scholar
• Cheung TC, Humphreys IR, Potter KG, Norris PS, Shumway HM, Tran BR, Patterson G, Jean-Jaques R, Yoon M, Spear PG, Murphy KM, Lurain NS, Benedict CA, Ware CF. Evolutionarily divergent herpesviruses modulate T-cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc Natl Acad Sci USA. 2005;102:13218–13223.
   PubMed Web of Science ®Google Scholar
• Morel Y, Schiano de Colella JM, Harrop J, Deen KC, Holmes SD, Wattam TA, Khandekar SS, Truneh A, Sweet RW, Gestaut JA, Olive D, Costello RT. Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol. 2000;165: 4397–4404.
   PubMed Web of Science ®Google Scholar